Ratings by Raymond James (Michael Gibbs)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/31/2023 | Freeport-McMoRan | FCX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/6/2021 | Freeport-McMoRan | FCX | Upgrade | Outperform (Market Perform) |
33.76 (48.32) |
43.13% | Details | |
| 11/28/2018 | DaVita | DVA | Upgrade | Outperform (Market Perform) |
60.78 (132.70) |
118.33% | Details | |
| 11/8/2018 | DaVita | DVA | Downgrade | Market Perform (Strong Buy) |
69.25 (60.78) |
-12.23% | Details | |
| 10/22/2018 | Incyte | INCY | Upgrade | Strong Buy (Outperform) |
64.44 (50.57) |
-21.52% | Details |
